Insurance review in Phase 1 clinical trials
Date: 19 January 2026
On 28 April 2026, new regulations for Clinical Trials will come into effect – the most significant updates in two decades. To support a smooth transition, the Medicines and Healthcare products Regulatory Agency (MHRA) and the Health Research Authority (HRA) are working together to provide updated guidance and information about key changes for industry.
This joint blog, sets out to clarify the insurance requirements for Phase 1 clinical trials.
Read here: https://mhrainspectorate.blog.gov.uk/2025/11/25/insurance-review-in-phase-1-clinical-trials/